Sinomenine inhibits microglia activation and attenuates brain injury in intracerebral hemorrhage

Molecular Immunology

Volumn 60, Issue 2, 2014, Pages 109-114

  Yang, Zhao ^a   Liu, Yongping ^a   Yuan, Fang ^a   Li, Zhen ^a   Huang, Shaokuan ^a   Shen, Hanchao ^a   Yuan, Bangqing ^a  

^a The 476th Hospital of PLA   (China)

Author keywords

Intracerebral hemorrhage; Microglia; Sinomenine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SINOMENINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN WATER; CELL ACTIVATION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HEMOLYSIS; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

INTRACEREBRAL HEMORRHAGE; MICROGLIA; SINOMENINE;

ANIMALS; BRAIN INJURIES; CELL LINE; CELL MOVEMENT; CEREBRAL HEMORRHAGE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MORPHINANS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899871020     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.03.005     Document Type: Article

References (29)

1. Angileri F.F., Cardali S., Conti A., Raffa G., Tomasello F. Telemedicine-assisted treatment of patients with intracerebral hemorrhage. Neurosurg. Focus 2012, 32:E6.
2. Baginska J., Viry E., Berchem G., Poli A., Noman M.Z., van Moer K., et al. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:17450-17455.
3. Beslow L.A., Licht D.J., Smith S.E., Storm P.B., Heuer G.G., Zimmerman R.A., et al. Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke 2010, 41:313-318.
4. Chen D.P., Wong C.K., Leung P.C., Fung K.P., Lau C.B., Lau C.P., et al. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-alpha-activated human fibroblast-like synoviocytes in rheumatoid arthritis. J. Ethnopharmacol. 2011, 137:457-468.
5. Chen G., Zhang W., Li Y.P., Ren J.G., Xu N., Liu H., et al. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma?. Cardiovasc. Res. 2013, 98:437-448.
6. Christensen M.C., Mayer S., Ferran J.M. Quality of life after intracerebral hemorrhage: results of the factor seven for acute hemorrhagic stroke (fast) trial. Stroke 2009, 40:1677-1682.
7. Ducruet A.F., Zacharia B.E., Hickman Z.L., Grobelny B.T., Yeh M.L., Sosunov S.A., et al. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp. Neurol. 2009, 219:398-403.
8. Gong C., Hoff J.T., Keep R.F. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000, 871:57-65.
9. Graffagnino C., Bergese S., Love J., Schneider D., Lazaridis C., Lapointe M., et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the accelerate trial. Cerebrovasc. Dis. 2013, 36:173-180.
10. Gregson B.A., Rowan E.N., Mitchell P.M., Unterberg A., McColl E.M., Chambers I.R., et al. Surgical trial in traumatic intracerebral hemorrhage (STITCH(trauma)): study protocol for a randomized controlled trial. Trials 2012, 13:193.
11. Huttner H.B., Kohrmann M., Tognoni E., Juttler E., Richter G., Dorfler A., et al. Clinical severity predicts time to hospital admission in patients with spontaneous intracerebral hemorrhage. Cerebrovasc. Dis. 2008, 25:533-538.
12. Keep R.F., Xi G., Hua Y., Hoff J.T. The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important?. Stroke 2005, 36:1594-1596.
13. Kok T.W., Yue P.Y., Mak N.K., Fan T.P., Liu L., Wong R.N. The anti-angiogenic effect of sinomenine. Angiogenesis 2005, 8:3-12.
14. Kuramatsu J.B., Huttner H.B., Schwab S. Advances in the management of intracerebral hemorrhage. J. Neural Transm. 2010, 120(Suppl. 1):S35-S41.
15. Leker R.R., Khoury S.T., Rafaeli G., Shwartz R., Eichel R., Tanne D. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009, 40:2581-2584.
16. Liu L., Riese J., Resch K., Kaever V. Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung 1994, 44:1223-1226.
17. Liu L., Buchner E., Beitze D., Schmidt-Weber C.B., Kaever V., Emmrich F., et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int. J. Immunopharmacol. 1996, 18:529-543.
18. Pouratian N., Kassell N.F., Dumont A.S. Update on management of intracerebral hemorrhage. Neurosurg. Focus 2003, 15:E2.
19. Qureshi A.I., Palesch Y.Y. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): II. Design, methods, and rationale. Neurocrit. Care 2011, 15:559-576.
20. Sykora M., Diedler J., Turcani P., Rupp A., Steiner T. Subacute perihematomal edema in intracerebral hemorrhage is associated with impaired blood pressure regulation. J. Neurol. Sci. 2009, 284:108-112.
21. Szymanska A., Biernaskie J., Laidley D., Granter-Button S., Corbett D. Minocycline and intracerebral hemorrhage: influence of injury severity and delay to treatment. Exp. Neurol. 2006, 197:189-196.
22. Teng P., Liu H.L., Zhang L., Feng L.L., Huai Y., Deng Z.S., et al. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents. Eur. J. Med. Chem. 2012, 50:63-74.
23. Wang Y.C., Wang P.F., Fang H., Chen J., Xiong X.Y., Yang Q.W. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 2013, 44:2545-2552.
24. Wu G., Sun S., Sheng F., Wang L., Wang F. Perihematomal glutamate level is associated with the blood-brain barrier disruption in a rabbit model of intracerebral hemorrhage. SpringerPlus 2013, 2:358.
25. Xi G., Keep R.F., Hoff J.T. Pathophysiology of brain edema formation. Neurosurg. Clin. North Am. 2002, 13:371-383.
26. Xu C., Wang T., Cheng S., Liu Y. Increased expression of T cell immunoglobulin and mucin domain 3 aggravates brain inflammation via regulation of the function of microglia/macrophages after intracerebral hemorrhage in mice. J. Neuroinflammation 2013, 10:141.
27. Zhao X., Sun G., Zhang J., Strong R., Song W., Gonzales N., et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann. Neurol. 2007, 61:352-362.
28. Zhao X.X., Peng C., Zhang H., Qin L.P. Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm. Biol. 2012, 50:1053-1061.
29. Zuo Y., Cheng G., Gao D.K., Zhang X., Zhen H.N., Zhang W., et al. Gross-total hematoma removal of hypertensive basal ganglia hemorrhages: a long-term follow-up. J. Neurol. Sci. 2009, 287:100-104.